Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
28 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Queensland Children'S Hospital
South Brisbane, Queensland, Australia
- Austin Health
Heidelberg, Victoria, Australia
- Alfred Health
Melbourne, Victoria, Australia
- Arkansas Children'S Hospital
Little Rock, Arkansas, United States
- Rancho Los Amigos National Rehabilitation Center (rlanrc)
Downey, California, United States
- University of California San Francisco
San Francisco, California, United States
- Northwest Florida Clinical Research Group
Gulf Breeze, Florida, United States
- University of Miami
Miami, Florida, United States
- Advent Health Orlando
Orlando, Florida, United States
- Research Institute of Orlando
Orlando, Florida, United States
- University of South Florida
Tampa, Florida, United States
- Hawaii Pacific Neuroscience
Honolulu, Hawaii, United States
- Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
- Mid-Atlantic Epilepsy and Sleep Center
Bethesda, Maryland, United States
- Spectrum Health
Grand Rapids, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Boston Children'S Health Physicians Llp
Hawthorne, New York, United States
- Northwell Health
New York, New York, United States
- Northeast Regional Epilepsy Group
Staten Island, New York, United States
- Onsite Clinical Solutions Llc
Charlotte, North Carolina, United States
- Wake Forest University School of Medicine
Winston-Salem, North Carolina, United States
- University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
- Providence Neurological Specialties-East
Portland, Oregon, United States
- Austin Epilepsy Care Center
Austin, Texas, United States
- Child Neurology Consultants of Austin
Austin, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
- University of Washington Valley Medical Center
Renton, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Nov 2022
- Primary completion
- 20 Dec 2024
- Completion
- 20 Dec 2024
- Last update posted
- 3 Dec 2025
- Registered enrollment
- 41
- Registry id
- NCT05626634
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.